Toll Free: 1-888-928-9744

Colby Pharmaceutical Company - Product Pipeline Review - 2015

Published: Jun, 2015 | Pages: 28 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Colby Pharmaceutical Company - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Colby Pharmaceutical Company - Product Pipeline Review - 2015', provides an overview of the Colby Pharmaceutical Company's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Colby Pharmaceutical Company's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Colby Pharmaceutical Company including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Colby Pharmaceutical Company's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Colby Pharmaceutical Company's pipeline products

Reasons to buy

- Evaluate Colby Pharmaceutical Company's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Colby Pharmaceutical Company in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Colby Pharmaceutical Company's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Colby Pharmaceutical Company and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Colby Pharmaceutical Company
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Colby Pharmaceutical Company and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Colby Pharmaceutical Company Snapshot 5 Colby Pharmaceutical Company Overview 5 Key Information 5 Key Facts 5 Colby Pharmaceutical Company - Research and Development Overview 6 Key Therapeutic Areas 6 Colby Pharmaceutical Company - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Colby Pharmaceutical Company - Pipeline Products Glance 10 Colby Pharmaceutical Company - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Phase I Products/Combination Treatment Modalities 11 Colby Pharmaceutical Company - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Colby Pharmaceutical Company - Unknown Stage Pipeline Products 13 Unknown Products/Combination Treatment Modalities 13 Colby Pharmaceutical Company - Drug Profiles 14 CPC-551 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 JVRS-100 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 JVRSOD 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Vaccine for Prostate Cancer 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 CPC-123 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Colby Pharmaceutical Company - Pipeline Analysis 20 Colby Pharmaceutical Company - Pipeline Products by Target 20 Colby Pharmaceutical Company - Pipeline Products by Route of Administration 21 Colby Pharmaceutical Company - Pipeline Products by Molecule Type 22 Colby Pharmaceutical Company - Pipeline Products by Mechanism of Action 23 Colby Pharmaceutical Company - Recent Pipeline Updates 24 Colby Pharmaceutical Company - Dormant Projects 25 Colby Pharmaceutical Company - Locations And Subsidiaries 26 Head Office 26 Other Locations & Subsidiaries 26 Appendix 27 Methodology 27 Coverage 27 Secondary Research 27 Primary Research 27 Expert Panel Validation 27 Contact Us 27 Disclaimer 28
List of Tables
Colby Pharmaceutical Company, Key Information 5 Colby Pharmaceutical Company, Key Facts 5 Colby Pharmaceutical Company - Pipeline by Indication, 2015 7 Colby Pharmaceutical Company - Pipeline by Stage of Development, 2015 8 Colby Pharmaceutical Company - Monotherapy Products in Pipeline, 2015 9 Colby Pharmaceutical Company - Phase II, 2015 10 Colby Pharmaceutical Company - Phase I, 2015 11 Colby Pharmaceutical Company - Preclinical, 2015 12 Colby Pharmaceutical Company - Unknown, 2015 13 Colby Pharmaceutical Company - Pipeline by Target, 2015 20 Colby Pharmaceutical Company - Pipeline by Route of Administration, 2015 21 Colby Pharmaceutical Company - Pipeline by Molecule Type, 2015 22 Colby Pharmaceutical Company - Pipeline Products by Mechanism of Action, 2015 23 Colby Pharmaceutical Company - Recent Pipeline Updates, 2015 24 Colby Pharmaceutical Company - Dormant Developmental Projects,2015 25 Colby Pharmaceutical Company, Subsidiaries 26



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify